{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:49:43Z","timestamp":1792612183691,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008383","name":"Stichting ParkinsonFonds","doi-asserted-by":"crossref","award":["Stichting ParkinsonFonds"],"award-info":[{"award-number":["Stichting ParkinsonFonds"]}],"id":[{"id":"10.13039\/501100008383","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015998","name":"ParkinsonFonds Deutschland","doi-asserted-by":"publisher","award":["ParkinsonFonds Deutschland"],"award-info":[{"award-number":["ParkinsonFonds Deutschland"]}],"id":[{"id":"10.13039\/100015998","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00259-025-07260-9","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:21:27Z","timestamp":1743981687000},"page":"3550-3556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Parkinson\u2019s Disease-Related pattern in isolated REM sleep behaviour disorder as a prodromal progression marker: 8-Year Follow-Up changes assessed at three time points"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-2031","authenticated-orcid":false,"given":"Giulia","family":"Carli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2530-2207","authenticated-orcid":false,"given":"Anna","family":"Dortmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Janzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"De Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus L.","family":"Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Meles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"7260_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","volume":"43","author":"A Galbiati","year":"2019","unstructured":"Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. 2019;43:37\u201346.","journal-title":"Sleep Med Rev"},{"key":"7260_CR2","first-page":"73","volume-title":"From positron to pattern: A conceptual and practical overview of 18F-FDG PET imaging and Spatial covariance analysis. PET and SPECT in neurology","author":"SK Meles","year":"2021","unstructured":"Meles SK, Kok JG, Renken RJ, Leenders KL. From positron to pattern: A conceptual and practical overview of 18F-FDG PET imaging and Spatial covariance analysis. PET and SPECT in neurology. Cham: Springer International Publishing; 2021. pp. 73\u2013104."},{"key":"7260_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(18)30169-8","volume":"17","author":"KA Schindlbeck","year":"2018","unstructured":"Schindlbeck KA, Eidelberg D. Network imaging biomarkers: insights and clinical applications in Parkinson\u2019s disease. Lancet Neurol. 2018;17:629\u201340.","journal-title":"Lancet Neurol"},{"key":"7260_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/WNL.0000000000000130","volume":"82","author":"F Holtbernd","year":"2014","unstructured":"Holtbernd F, Gagnon J-F, Postuma RB, Ma Y, Tang CC, Feigin A, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82:620\u20137.","journal-title":"Neurology"},{"key":"7260_CR5","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1093\/brain\/awu290","volume":"137","author":"P Wu","year":"2014","unstructured":"Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J, et al. Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2014;137:3122\u20138.","journal-title":"Brain"},{"key":"7260_CR6","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/mds.28592","volume":"36","author":"R Kim","year":"2021","unstructured":"Kim R, Lee J-Y, Kim YK, Kim H, Yoon EJ, Shin JH, et al. Longitudinal changes in isolated rapid eye movement sleep behavior disorder-related metabolic pattern expression. Mov Disord. 2021;36:1889\u201398.","journal-title":"Mov Disord"},{"key":"7260_CR7","doi-asserted-by":"crossref","unstructured":"Orso B, Mattioli P, Yoon E-J, Kim YK, Kim H, Shin JH. Progression trajectories from prodromal overt synucleinopathies: longitudinal, multicentric brain [18F] FDG-PET study. NPJ Parkinsons Dis. 2024;10.","DOI":"10.1038\/s41531-024-00813-z"},{"key":"7260_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2967\/jnumed.117.202242","volume":"59","author":"SK Meles","year":"2018","unstructured":"Meles SK, Renken RJ, Janzen A, Vadasz D, Pagani M, Arnaldi D, et al. The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson disease. J Nucl Med. 2018;59:1437\u201344.","journal-title":"J Nucl Med"},{"key":"7260_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"7260_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"7260_CR11","doi-asserted-by":"crossref","unstructured":"Kogan RV, Meles SK, Sittig E, Renken RJ, Gurvits V. Four-Year Follow-up [18F] Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson\u2019s Disease-Related Pattern Expression 20 Patients Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression. Movement Disorders. 2020.","DOI":"10.1002\/mds.28260"},{"key":"7260_CR12","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.3233\/JPD-223201","volume":"12","author":"A Janzen","year":"2022","unstructured":"Janzen A, Vadasz D, Booij J, Luster M, Librizzi D, Henrich MT, et al. Progressive olfactory impairment and cardiac sympathetic denervation in REM sleep behavior disorder. J Parkinsons Dis. 2022;12:1921\u201335.","journal-title":"J Parkinsons Dis"},{"key":"7260_CR13","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30:1600\u201311.","journal-title":"Mov Disord"},{"key":"7260_CR14","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.nicl.2014.06.007","volume":"5","author":"LK Teune","year":"2014","unstructured":"Teune LK, Renken RJ, de Jong BM, Willemsen AT, van Osch MJ, Roerdink JBTM, et al. Parkinson\u2019s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging. NeuroImage Clin. 2014;5:240\u20134.","journal-title":"NeuroImage Clin"},{"key":"7260_CR15","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1007\/s00259-023-06299-w","volume":"50","author":"F Gu","year":"2023","unstructured":"Gu F, Wu Q. Quantitation of dynamic total-body PET imaging: recent developments and future perspectives. Eur J Nucl Med Mol Imaging. 2023;50:3538\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7260_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0271678X16637880","volume":"37","author":"JH Ko","year":"2017","unstructured":"Ko JH, Lee CS, Eidelberg D. Metabolic network expression in parkinsonism: clinical and dopaminergic correlations. J Cereb Blood Flow Metab. 2017;37:683\u201393.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7260_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S1474-4422(07)70245-4","volume":"6","author":"T Eckert","year":"2007","unstructured":"Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson\u2019s disease: a metabolic network approach. Lancet Neurol. 2007;6:926\u201332.","journal-title":"Lancet Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07260-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07260-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07260-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:36:08Z","timestamp":1757154968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07260-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7260"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07260-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WHO has received honoraria for educational presentations at symposia by AbbVie and Stada Pharma and in his role as a consultant\/member of an advisory board for the companies Intrabio, Lario Therapeutics and Modag. He holds stock options of the companies Intrabio and Modag and shares of the companies BioNTech, CureVac, Formycon and Medigene. There is no conflict of interest. S.K. Meles is funded by the Michael J. Fox Foundation (Edmond J. Safra Fellowship in Movement Disorders). All these activities and relations are unrelated to the work submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Study protocols were approved by the institutional review boards of University Medical Center of Groningen and the Philipps-University Marburg, and voluntary informed consent was obtained from each subject after verbal and written explanation of the study, in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Voluntary informed consent was obtained from each subject after verbal and written explanation of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}